Kenji Ikeda

29.5k citations

409 papers · 16.5k indexed · 4 hit papers · h-index 61

Hepatology top 0.05%
Epidemiology top 0.1%
Physiology top 0.5%
Molecular Biology top 2%
Neurology top 0.2%

Co-authors: Hiromitsu Kumada Yasuji Arase Masahiro Kobayashi Yoshiyuki Suzuki Fumitaka Suzuki Kuniaki Tsuchiya Satoshi Saitoh Norio Akuta
Topics: Hepatitis C virus research (166 papers)Liver Disease Diagnosis and Treatment (158 papers)Hepatocellular Carcinoma Treatment and Prognosis (99 papers)
Cited by: Hepatology Epidemiology Neurology
Journals: Nature Nature Medicine Nature Communications
Partner nations: Japan United States China

In The Last Decade

Kenji Ikeda

393 papers receiving 16.1k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

TDP-43 is a component of ubiquitin-positive tau-negative inclusions in frontotemporal lobar degeneration and amyotrophic lateral sclerosis

2006 2.1k citations Kenji Ikeda, Kuniaki Tsuchiya et al. profile →
Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinoma

2009 872 citations Yujin Hoshida, Sebastian Nijman et al. Cancer Research profile →
UCP1-independent signaling involving SERCA2b-mediated calcium cycling regulates beige fat thermogenesis and systemic glucose homeostasis

2017 442 citations Kenji Ikeda, Takeshi Yoneshiro et al. profile →
The Common and Distinct Features of Brown and Beige Adipocytes

2018 409 citations Kenji Ikeda, Pema Maretich et al. profile →

Peers

Countries citing papers authored by Kenji Ikeda

Since Specialization

Citations

This map shows the geographic impact of Kenji Ikeda's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kenji Ikeda with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kenji Ikeda more than expected).

Fields of papers citing papers by Kenji Ikeda

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kenji Ikeda. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kenji Ikeda. The network helps show where Kenji Ikeda may publish in the future.

Co-authorship network of co-authors of Kenji Ikeda

This figure shows the co-authorship network connecting the top 25 collaborators of Kenji Ikeda. A scholar is included among the top collaborators of Kenji Ikeda based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kenji Ikeda. Kenji Ikeda is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Artificial intelligence identifies individuals with prediabetes using single-lead electrocardiograms 2025 ·Cardiovascular Diabetology ·Daisuke Koga,(unknown),Chikara Komiya,(unknown),A. Takeuchi,(unknown),(unknown),Jun Aoki,(unknown),(unknown),Masanori Murakami,(unknown),Kenji Ikeda,Hideki Katagiri,Hideyuki Shimizu,Taku Yamada	0
2	Well-preserved liver function enhances the clinical impact of curative-intent subsequent treatment during lenvatinib treatment for unresectable hepatocellular carcinoma 2022 ·Clinical Journal of Gastroenterology ·Yusuke Kawamura,Norio Akuta,Junichi Shindoh,Masaru Matsumura,Satoshi Okubo,Licht Tominaga,Shunichiro Fujiyama,Tetsuya Hosaka,Satoshi Saitoh,Hitomi Sezaki,Fumitaka Suzuki,Yoshiyuki Suzuki,Kenji Ikeda,Yasuji Arase,Masaji Hashimoto,Takuyo Kozuka,Hiromitsu Kumada	5
3	Impact of bodyweight‐based starting doses on the safety and efficacy of lenvatinib in primarily Japanese patients with hepatocellular carcinoma 2022 ·Hepatology Research ·Takuji Okusaka,Masatoshi Kudo,Kenji Ikeda,Masafumi Ikeda,Kiwamu Okita,Michiko SUGAWARA,Toshiyuki Tamai,Min Ren,Kenichi Saito,Hiromitsu Kumada	1
4	Safety and efficacy of lenvatinib by starting dose based on body weight in patients with unresectable hepatocellular carcinoma in REFLECT 2021 ·Journal of Gastroenterology ·Takuji Okusaka,Kenji Ikeda,Masatoshi Kudo,Richard S. Finn,Shukui Qin,Kwang‐Hyub Han,Ann‐Lii Cheng,Fabio Piscaglia,Masahiro Kobayashi,Max W. Sung,Minshan Chen,Lucjan Wyrwicz,Jung‐Hwan Yoon,Zhenggang Ren,Kalgi Mody,Corina E. Dutcus,Toshiyuki Tamai,Min Ren,Seiichi Hayato,Hiromitsu Kumada	10
5	Long‐term outcome of hepatocellular carcinoma occurrence, esophageal varices exacerbation, and mortality in hepatitis C virus‐related liver cirrhosis after interferon‐based therapy 2019 ·Hepatology Research ·(unknown),Satoshi Saitoh,Norio Akuta,Shunichiro Fujiyama,Yusuke Kawamura,Hitomi Sezaki,Tetsuya Hosaka,Masahiro Kobayashi,Fumitaka Suzuki,Yoshiyuki Suzuki,Yasuji Arase,Kenji Ikeda,Hiromitsu Kumada	11
6	Mitophagy controls beige adipocyte maintenance through a Parkin-dependent and UCP1-independent mechanism 2018 ·Science Signaling ·Xiaodan Lü,Svetlana Altshuler-Keylin,Qiang Wang,Yong Chen,Carlos H. Sponton,Kenji Ikeda,Pema Maretich,Takeshi Yoneshiro,Shingo Kajimura	104
7	Rapid and high sensitive detection of Y93H amino acid substitution in HCV NS5A region using the PCR-Invader assay 2014 ·Kanzo ·(unknown),(unknown),(unknown),Yusuke Kawamura,Hitomi Sezaki,Tetsuya Hosaka,Norio Akuta,Masahiro Kobayashi,(unknown),Satoshi Saitoh,Yasuji Arase,Kenji Ikeda,Hiromitsu Kumada	12
8	Effectiveness of systemic chemotherapy using CBDCA and 5-FU in a case of hepatocellular carcinoma with metastases to the lung 2011 ·Kanzo ·(unknown),Yuji Kitamura,Hiroshi Shiga,Kenji Ikeda,(unknown),Hiroyuki Uno,Yoshiyuki Arita,Fumio Umeda,Tetsuro Sohda,Shotaro Sakisaka	0
9	Transcatheter arterial chemotherapy with miriplatin for patients with hepatocellular carcinoma and Child-Pugh B liver cirrhosis 2010 ·Kanzo ·Norihiro Imai,Kenji Ikeda,Yuya Seko,Miharu Hirakawa,Yusuke Kawamura,Tetsuya Hosaka,Masahiro Kobayashi,Satoshi Saitoh,Hitomi Sezaki,Norio Akuta,(unknown),Yoshiyuki Suzuki,Yasuji Arase,Hiromitsu Kumada	1
10	Integrative Transcriptome Analysis Reveals Common Molecular Subclasses of Human Hepatocellular Carcinomabreakdown → 2009 ·Cancer Research ·Yujin Hoshida,Sebastian Nijman,Masahiro Kobayashi,Jennifer A. Chan,(unknown),Derek Y. Chiang,Augusto Villanueva,Philippa Newell,Kenji Ikeda,Masaji Hashimoto,Goro Watanabe,Stacey Gabriel,Scott L. Friedman,Hiromitsu Kumada,Josep M. Llovet,Todd R. Golub	872
11	Development of hepatocellular carcinoma in elderly patients with chronic hepatitis C with or without elevated aspartate and alanine aminotransferase levels 2009 ·Scandinavian Journal of Gastroenterology ·Mariko Kobayashi,Fumitaka Suzuki,Norio Akuta,Yoshiyuki Suzuki,Hitomi Sezaki,Hiromi Yatsuji,Yusuke Kawamura,Tetsuya Hosaka,Masahiro Kobayashi,Yasuji Arase,Kenji Ikeda,Rie Mineta,Satomi Iwasaki,Sachiyo Watahiki,Yuzo Miyakawa,Hiromitsu Kumada	5
12	Influence of amino‐acid polymorphism in the core protein on progression of liver disease in patients infected with hepatitis C virus genotype 1b 2009 ·Journal of Medical Virology ·Mariko Kobayashi,Norio Akuta,Fumitaka Suzuki,Tetsuya Hosaka,Hitomi Sezaki,(unknown),(unknown),Yoshiyuki Suzuki,Yasuji Arase,Kenji Ikeda,Sachiyo Watahiki,Rie Mineta,Satomi Iwasaki,Yuzo Miyakawa,Hiromitsu Kumada	21
13	Influence of HMG-CoA reductase inhibitor to virological response of peginterferon/ribavirin combination therapy in chronic hepatitis C 2008 ·Kanzo ·Hitomi Sezaki,Fumitaka Suzuki,Norio Akuta,Yusuke Kawamura,Hiromi Yatsuji,Tetsuya Hosaka,Masahiro Kobayashi,Yoshiyuki Suzuki,Satoshi Saitoh,Yasuji Arase,Kenji Ikeda,Hiromitsu Kumada	3
14	Re-evaluation of chronic hepatitis C patients who showed viral relapse after interferon plus ribavirin therapy by COBAS AmpliPrep/ COBAS Taq Man HCV Test 2007 ·Kanzo ·(unknown),(unknown),Norio Akuta,Yoshiyuki Suzuki,Tetsuya Hosaka,Hitomi Sezaki,Hiromi Yatsuji,Yusuke Kawamura,Masahiro Kobayashi,Kenji Ikeda,Yasuji Arase,Satomi Iwasaki,Rie Mineta,Sachiyo Watahiki,Hiromitsu Kumada	0
15	Forefront of radiofrequency ablation treatment of hepatic cancer. 2. Comparison of the equipment for radiofrequency ablation therapy. 2005 ·Kanzo ·Kenji Ikeda	1
16	Pick body disease and Pick syndrome* 2003 ·Neuropathology ·Toshiki Uchihara,Kenji Ikeda,Kuniaki Tsuchiya	27
17	Long-term observation of four patients with early stage of primary biliary cirrhosis(PBC). 1997 ·Kanzo ·Yoshiyuki Suzuki,Kenji Ikeda,Satoshi Saitoh,Masahiro Kobayashi,Akihito Tsubota,Isao Koida,Naoya Murashima,Yasuji Arase,Kazuaki Chayama,(unknown),Marie Matsuda,Mariko Kobayashi,Hiromitsu Kumada	0
18	Early diagnosis of small hepatocellular carcinoma with PIVKA-II determined by Abidin-Biotin complex method. 1993 ·Kanzo ·Satoshi Saitô,Kenji Ikeda,Isao Koida,Akihito Tsubota,Yasuji Arase,(unknown),Mariko Kobayashi,(unknown),Satomi Iwasaki,Hiromitsu Kumada	1
19	Interferon therapy for chronic hepatitis C. 1991 ·Kanzo ·Yasuji Arase,Hiromitsu Kumada,Kazuaki Chayama,Satoshi Saitô,Kenji Ikeda,Toyomi MATSUMOTO,Yoko Sakai,Mariko Kobayashi,Masamitsu Unakami	6
20	Two operated cases of small bowel metastases from primary lung cancer. 1990 ·Haigan ·Kenji Ikeda,Akio Nakashima,Hiroshi Fujita,Akihiko Ikeda,Mitsuhiro Tsukino	2

About Kenji Ikeda

Kenji Ikeda is a scholar working on Hepatology, Epidemiology and Neurology, having authored 409 papers that have together received 16.5k indexed citations. Recurring topics across this work include Hepatitis C virus research (166 papers), Liver Disease Diagnosis and Treatment (158 papers) and Hepatocellular Carcinoma Treatment and Prognosis (99 papers). The work is most often cited by research in Hepatology (8.2k citations), Epidemiology (7.3k citations) and Neurology (2.9k citations). Kenji Ikeda has collaborated with scholars based in Japan, United States and China. Frequent co-authors include Hiromitsu Kumada, Yasuji Arase, Masahiro Kobayashi, Yoshiyuki Suzuki, Fumitaka Suzuki, Kuniaki Tsuchiya, Satoshi Saitoh, Norio Akuta, Haruhiko Akiyama and Tetsuya Hosaka. Their work appears in journals such as Nature, Nature Medicine and Nature Communications.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact